跳转至内容
Merck
CN

T1573

凝血酶受体活化因子肽 6

>95% (HPLC)

别名:

TRAP-6

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C34H56N10O9
化学文摘社编号:
141136-83-6
分子量:
748.87
NACRES:
NA.77
PubChem Substance ID:
329826680
UNSPSC Code:
12352200
MDL number:
MFCD00238172
Form:
lyophilized
Assay:
>95% (HPLC)

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

凝血酶受体活化因子肽 6, >95% (HPLC)

solubility

water: soluble
0.1% TFA: soluble

InChI key

HAGOWCONESKMDW-FRSCJGFNSA-N

SMILES string

CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O

InChI

1S/C34H56N10O9/c1-18(2)13-23(30(49)40-22(11-8-12-39-34(37)38)29(48)44-26(33(52)53)16-27(36)46)42-31(50)24(14-19(3)4)43-32(51)25(41-28(47)21(35)17-45)15-20-9-6-5-7-10-20/h5-7,9-10,18-19,21-26,45H,8,11-17,35H2,1-4H3,(H2,36,46)(H,40,49)(H,41,47)(H,42,50)(H,43,51)(H,44,48)(H,52,53)(H4,37,38,39)/t21-,22-,23-,24-,25-,26-/m0/s1

assay

>95% (HPLC)

form

lyophilized

technique(s)

cell culture | mammalian: suitable

UniProt accession no.

P25116

storage temp.

−20°C

Quality Level

200

Gene Information

human ... F2R(2149)

Application

凝血酶受体激活物肽6已在体外被用于激活血小板。它也已被用于下调hippo信号并上调核yes相关蛋白（YAP）。

Biochem/physiol Actions

凝血酶受体的六肽片段（残基 42-47）。
凝血酶受体的六肽片段（残基 42-47）。可激活凝血酶受体并引起血小板聚集 (EC 50 = 0.8 μM)。

General description

凝血酶受体激活肽6（TRAP-6）可保护星形胶质细胞免于细胞死亡，其与低血糖症有关。在流动条件下，TRAP-6会诱导聚集并损害胶原蛋白的附着力。

Other Notes

从 0.1%TFA 水溶液冻干

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

常规特殊物品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000430567
0000430567
0000278383
0000278383
0000177732

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Xavier Charest-Morin et al.
Frontiers in immunology, 9, 2183-2183 (2018-10-20)
Multiple pathways have been proposed to generate bradykinin (BK)-related peptides from blood. We applied various forms of activation to fresh blood obtained from 10 healthy subjects or 10 patients with hereditary angioedema (HAE-1 or -2 only) to investigate kinin formation.
Saskia Wand et al.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 24(1), 179-185 (2017-03-18)
We aimed to identify the prevalence of acetylsalicylic acid (ASA) nonresponse in patients after coronary artery bypass graft (CABG) surgery and the possible consequences for the rate of major cardiovascular events. This prospective, observational, bicentric cohort study was conducted in
Hematology: Basic Principles and Practice E-Book: Basic Principles and Practice (2017)
Kristoffer Navred et al.
PloS one, 14(1), e0211130-e0211130 (2019-01-24)
Flow cytometric platelet activation has emerged as an alternative diagnostic test for inherited platelet disorders. It is, however, labor intensive and few studies have directly compared the performance of flow cytometric platelet activation (PACT) to light transmission aggregometry (LTA). The
Juergen Koessler et al.
PloS one, 12(11), e0188193-e0188193 (2017-11-21)
Platelets are important for effective hemostasis and considered to be involved in pathophysiological processes, e.g. in cardiovascular diseases. Platelets provided for research or for therapeutic use are frequently separated from citrated whole blood (WB) stored for different periods of time.
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持